INS and metabolic dysfunction-associated steatotic liver disease: The correlation between insulin signaling impairment in PCOS, the factors causing insulin resistance in patients, and the association between NAFLD and PCOS have been explored; further, the inflammatory markers elevated in PCOS that are interconnected to liver function, the metabolic effects of both PCOS and NAFLD, and the role that genetics plays in both conditions have been discussed.